S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
S&P 500   4,986.30 (-0.50%)
DOW   37,923.01 (+0.39%)
QQQ   418.52 (-1.15%)
AAPL   165.02 (-1.21%)
MSFT   401.42 (-0.70%)
META   487.91 (-2.77%)
GOOGL   154.64 (-0.88%)
AMZN   176.10 (-1.74%)
TSLA   149.52 (-0.27%)
NVDA   821.64 (-2.96%)
AMD   149.78 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.86 (-0.03%)
T   16.34 (+0.06%)
F   12.12 (+0.50%)
MU   107.92 (-3.58%)
GE   150.69 (-1.47%)
CGC   8.04 (+2.68%)
DIS   111.69 (-0.66%)
AMC   3.19 (+9.25%)
PFE   25.81 (+1.65%)
PYPL   62.05 (-0.08%)
XOM   120.04 (+1.28%)
Free Trial
NYSE:MDP

Meredith (MDP) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free MDP Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$58.04
▼
$59.07
52-Week Range
N/A
Volume
3.36 million shs
Average Volume
552,848 shs
Market Capitalization
$2.70 billion
P/E Ratio
10.01
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
MDP stock logo

About Meredith Stock (NYSE:MDP)

Meredith Corp. engages in television broadcasting and magazine advertising business. It operates through the Local Media and National Media business segments. The Local Media segment includes television stations and offers websites, mobile-optimized websites, and mobile applications. The National Media segment consists of national consumer media brands delivered via multiple media platforms including print magazines and digital and mobile media, brand licensing activities, database-related activities, and business-to-business marketing products and services. The company was founded by Edwin Thomas Meredith in 1902 and is headquartered in Des Moines, IA.

MDP Stock News Headlines

November 8, 2023 | investorplace.com
Legendary Investor Meredith Whitney Just Issued a Big Housing Market Warning
January 31, 2023 | finance.yahoo.com
Medexus Pharmaceuticals Inc. (TSE:MDP): Are Analysts Optimistic?
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
November 11, 2022 | finance.yahoo.com
Medexus Pharmaceuticals Second Quarter 2023 Earnings: Beats Expectations
November 8, 2022 | finance.yahoo.com
Medexus Announces Strongest Quarter in Company History with Fiscal Q2 2023 Revenue of US$27.7 Million, a 55% Increase Over Fiscal Q2 2022
October 6, 2022 | finance.yahoo.com
Medexus Announces Preliminary Revenue Results for Second Fiscal Quarter 2023
September 19, 2022 | finance.yahoo.com
Medexus Provides Update on Treosulfan NDA Resubmission and Provides Business Update
September 15, 2022 | finance.yahoo.com
Medexus Holds Annual Meeting of Shareholders and Announces Election of Board of Directors
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
August 17, 2022 | theglobeandmail.com
Medexus Pharma MDP is in the bottom 25 performing stocks year-to-date on the Toronto Stock Exchange
August 9, 2022 | seekingalpha.com
Medexus Pharmaceuticals Inc. (MEDXF) CEO Ken d'Entremont on Q1 2023 Results - Earnings Call Transcript
August 8, 2022 | finance.yahoo.com
Medexus Announces Record Fiscal Q1 2023 Revenue of US$23.0 Million, a 33% Increase versus Fiscal Q1 2022
November 23, 2021 | finance.yahoo.com
Meredith Corporation Announces Winners of Good Impressions Program
October 9, 2021 | benzinga.com
What Does Meredith's Debt Look Like?
October 8, 2021 | finance.yahoo.com
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Meredith Corporation (NYSE - MDP)
See More Headlines
Receive MDP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Meredith and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/28/2021
Today
4/19/2024
Fiscal Year End
6/30/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Consumer Staples
Industry
Periodicals
Sub-Industry
Publishing
Current Symbol
NYSE:MDP
CUSIP
58943310
CIK
65011
Web
www.meredith.com
Phone
(515) 284-3000
Fax
515-284-2700
Employees
5,330
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
$5.90
Trailing P/E Ratio
10.01
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$306.60 million
Net Margins
9.66%
Pretax Margin
13.12%
Return on Equity
41.72%
Return on Assets
4.92%

Debt

Debt-to-Equity Ratio
4.03
Current Ratio
1.39
Quick Ratio
1.36

Sales & Book Value

Annual Sales
$2.98 billion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
5.68
Book Value
$14.27 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
45,781,000
Free Float
41,299,000
Market Cap
$2.70 billion
Optionable
Optionable
Beta
2.07
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Thomas H. Harty
    Chairman, President & Chief Executive Officer
  • Jason M. Frierott
    Chief Financial & Accounting Officer
  • Michael Brownstein
    Chief Revenue Officer & Executive Vice President
  • Steven M. Cappaert
    Senior Vice President & Controller
  • Charlie Henrich
    Vice President & General Manager

Key Competitors

View All Competitors

MDP Stock Analysis - Frequently Asked Questions

How were Meredith's earnings last quarter?

Meredith Co. (NYSE:MDP) posted its earnings results on Thursday, October, 28th. The company reported $0.86 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.68 by $0.18. The business earned $708.60 million during the quarter, compared to analyst estimates of $681.84 million. Meredith had a trailing twelve-month return on equity of 41.72% and a net margin of 9.66%. The company's revenue for the quarter was up 2.2% compared to the same quarter last year. During the same quarter last year, the firm earned $1.04 earnings per share.

What is Steve Lacy's approval rating as Meredith's CEO?

231 employees have rated Meredith Chief Executive Officer Steve Lacy on Glassdoor.com. Steve Lacy has an approval rating of 78% among the company's employees.

What other stocks do shareholders of Meredith own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Meredith investors own include AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), Exxon Mobil (XOM), Cisco Systems (CSCO), Chevron (CVX), Energy Transfer (ET), Pfizer (PFE), Gilead Sciences (GILD) and Altria Group (MO).

This page (NYSE:MDP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
1970’s computer coder issues shocking A.I. warning
TradeSmith
Top 5 AI Stocks to Buy for 2024
Market Moving Trends